Beta blockers and their combinations in the management of hypertension
| dc.contributor.author | Ker, James A. | |
| dc.contributor.email | kames.ker@up.ac.za | en_US |
| dc.date.accessioned | 2012-11-30T07:12:02Z | |
| dc.date.available | 2012-11-30T07:12:02Z | |
| dc.date.issued | 2012-09 | |
| dc.description.abstract | Beta blockers have been prescribed for the treatment of primary hypertension for a very long time. Currently, it is doubtful whether this is still a good idea. In fact, many are of the opinion that beta blockers should be relegated to a fourth-line drug, if used at all, for the treatment of hypertension. So what happened? Why the change of heart? Basically, two issues are driving this new view of beta blockers. | en_US |
| dc.description.uri | www.safpj.co.za | en_US |
| dc.identifier.citation | Ker, JA 2012, 'Beta blockers and their combinations in the management of hypertension', South African Family Practice, vol. 54, no. 5, pp. 409-410. | en_US |
| dc.identifier.issn | 1026-9177 (print) | |
| dc.identifier.issn | 1726-426X (online) | |
| dc.identifier.uri | http://hdl.handle.net/2263/20609 | |
| dc.language.iso | en | en_US |
| dc.publisher | South African Academy of Family Practice/Primary Care | en_US |
| dc.rights | © Medpharm | en_US |
| dc.subject | Hypertension | en_US |
| dc.subject.lcsh | Adrenergic beta blockers | en |
| dc.subject.lcsh | Hypertension -- Treatment | en |
| dc.subject.lcsh | Cerebrovascular disease | en |
| dc.title | Beta blockers and their combinations in the management of hypertension | en_US |
| dc.type | Article | en_US |